These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 36549916)
1. Distinguishing Progression from Pseudoprogression in Glioblastoma Using Nabavizadeh A; Bagley SJ; Doot RK; Ware JB; Young AJ; Ghodasara S; Zhao C; Anderson H; Schubert E; Carpenter EL; Till J; Henderson F; Pantel AR; Chen HI; Lee JYK; Amankulor NM; O'Rourke DM; Desai A; Nasrallah MP; Brem S J Nucl Med; 2023 Jun; 64(6):852-858. PubMed ID: 36549916 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Henderson F; Brem S; O'Rourke DM; Nasrallah M; Buch VP; Young AJ; Doot RK; Pantel A; Desai A; Bagley SJ; Nabavizadeh SA Neurooncol Pract; 2020 Mar; 7(2):152-157. PubMed ID: 32206320 [TBL] [Abstract][Full Text] [Related]
4. Serial FLT PET imaging to discriminate between true progression and pseudoprogression in patients with newly diagnosed glioblastoma: a long-term follow-up study. Brahm CG; den Hollander MW; Enting RH; de Groot JC; Solouki AM; den Dunnen WFA; Heesters MAAM; Wagemakers M; Verheul HMW; de Vries EGE; Pruim J; Walenkamp AME Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2404-2412. PubMed ID: 30032322 [TBL] [Abstract][Full Text] [Related]
5. Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers. Ulaner GA; Goldman DA; Gönen M; Pham H; Castillo R; Lyashchenko SK; Lewis JS; Dang C J Nucl Med; 2016 Sep; 57(9):1350-6. PubMed ID: 26940766 [TBL] [Abstract][Full Text] [Related]
6. Validation of multiparametric MRI based prediction model in identification of pseudoprogression in glioblastomas. de Godoy LL; Mohan S; Wang S; Nasrallah MP; Sakai Y; O'Rourke DM; Bagley S; Desai A; Loevner LA; Poptani H; Chawla S J Transl Med; 2023 Apr; 21(1):287. PubMed ID: 37118754 [TBL] [Abstract][Full Text] [Related]
7. Determining the extent of tumor resection at surgical planning with Wakabayashi T; Hirose Y; Miyake K; Arakawa Y; Kagawa N; Nariai T; Narita Y; Nishikawa R; Tsuyuguchi N; Fukami T; Sasaki H; Sasayama T; Kondo A; Iuchi T; Matsuda H; Kubota K; Minamimoto R; Terauchi T; Nakazato Y; Kubomura K; Wada M Ann Nucl Med; 2021 Dec; 35(12):1279-1292. PubMed ID: 34406623 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of Pseudoprogression Following Lomustine-Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET. Werner JM; Weller J; Ceccon G; Schaub C; Tscherpel C; Lohmann P; Bauer EK; Schäfer N; Stoffels G; Baues C; Celik E; Marnitz S; Kabbasch C; Gielen GH; Fink GR; Langen KJ; Herrlinger U; Galldiks N Clin Cancer Res; 2021 Jul; 27(13):3704-3713. PubMed ID: 33947699 [TBL] [Abstract][Full Text] [Related]
9. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial. Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434 [TBL] [Abstract][Full Text] [Related]
10. Exploratory Analysis of Serial Fatania K; Frood R; Tyyger M; McDermott G; Fernandez S; Shaw GC; Boissinot M; Salvatore D; Ottobrini L; Teh I; Wright J; Bailey MA; Koch-Paszkowski J; Schneider JE; Buckley DL; Murray L; Scarsbrook A; Short SC; Currie S Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884545 [TBL] [Abstract][Full Text] [Related]
11. Albano D; Tomasini D; Bonù M; Giubbini R; Bertagna F Ann Nucl Med; 2020 Feb; 34(2):81-86. PubMed ID: 31773466 [No Abstract] [Full Text] [Related]
15. Imaging Glioblastoma With Scarpelli ML; Healey DR; Mehta S; Quarles CC Front Oncol; 2022; 12():829050. PubMed ID: 35174096 [TBL] [Abstract][Full Text] [Related]
16. Glioblastoma PET/MRI: kinetic investigation of [ Lindemann M; Oteiza A; Martin-Armas M; Guttormsen Y; Moldes-Anaya A; Berzaghi R; Bogsrud TV; Bach-Gansmo T; Sundset R; Kranz M Eur J Nucl Med Mol Imaging; 2023 Mar; 50(4):1183-1194. PubMed ID: 36416908 [TBL] [Abstract][Full Text] [Related]
17. Differentiating Tumor Progression from Pseudoprogression in Patients with Glioblastomas Using Diffusion Tensor Imaging and Dynamic Susceptibility Contrast MRI. Wang S; Martinez-Lage M; Sakai Y; Chawla S; Kim SG; Alonso-Basanta M; Lustig RA; Brem S; Mohan S; Wolf RL; Desai A; Poptani H AJNR Am J Neuroradiol; 2016 Jan; 37(1):28-36. PubMed ID: 26450533 [TBL] [Abstract][Full Text] [Related]